UC student research targets tick-borne illness
Nigerian student works to address Lyme disease
The Guardian highlighted student biology research that is pursuing pesticide-free ways of preventing tick-borne illness.
A dog tick in a UC biology lab. UC is studying ways to address tick-borne illness. Photo/Jay Yocis/UC
In UC College of Arts and Sciences Professor Joshua Benoit's lab, doctoral student Kosisochukwu Onyeagba is studying how to exploit a tick's ability to sense humidity to kill them. Ticks use a specialized organ to find refuge to survive dry conditions.
But if researchers find a way to disrupt the organ, the tick will die from dehydration.
“The idea is to outsmart them, not just eliminate them,” Onyeagba told the Guardian. “We’re targeting behavior, not biology. No toxicity. No resistance.”
Nearly a half-million people in the United States contract Lyme disease each year, according to the Centers for Disease Control and Prevention. The disease is most prevalent in the Northeast but it has been reported in all 50 states.
Onyeagba was a co-author on a study published in BioRxix, a pre-print server that allows researchers to share results and solicit feedback before pursuing publication in a peer-reviewed journal.
Featured image at top: UC biology students are studying ways to prevent tick-borne illness. Photo/Joseph Fuqua II/UC
Related Stories
Ohio recognizes colleges that support student veterans
June 8, 2026
Cleveland.com highlights an Ohio program that recognizes UC and other universities that provide support for student veterans.
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
Nanofiber multidrug offers new strategy for glioblastoma
June 8, 2026
Science and medical outlets highlight multidrug nanofiber to treat glioblastoma developed by the University of Cincinnati and Johns Hopkins Medicine.